Good morning, and welcome to Ocugen's Webcast to discuss the Top Line 12-month Results from Phase II ArMaDa Clinical Trial Evaluating OCU410 for Geographic Atrophy or GA Secondary to Dry Age-related ...
In a bid to better understand, and potentially treat, a host of conditions that affect early cognition, neurodevelopment and ...
Science Connected Magazine is an editorially independent, non-profit newsroom producing open-access science journalism and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results